Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

References for PMC Articles for PubMed (Select 15690085)

1.

Biochemical and functional analysis of smallpox growth factor (SPGF) and anti-SPGF monoclonal antibodies.

Kim M, Yang H, Kim SK, Reche PA, Tirabassi RS, Hussey RE, Chishti Y, Rheinwald JG, Morehead TJ, Zech T, Damon IK, Welsh RM, Reinherz EL.

J Biol Chem. 2004 Jun 11;279(24):25838-48. Epub 2004 Apr 7.

2.

Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus.

Wang X, Huong SM, Chiu ML, Raab-Traub N, Huang ES.

Nature. 2003 Jul 24;424(6947):456-61.

PMID:
12879076
3.

A Cortactin-CD2-associated protein (CD2AP) complex provides a novel link between epidermal growth factor receptor endocytosis and the actin cytoskeleton.

Lynch DK, Winata SC, Lyons RJ, Hughes WE, Lehrbach GM, Wasinger V, Corthals G, Cordwell S, Daly RJ.

J Biol Chem. 2003 Jun 13;278(24):21805-13. Epub 2003 Apr 2.

4.

Poxviruses and immune evasion.

Seet BT, Johnston JB, Brunetti CR, Barrett JW, Everett H, Cameron C, Sypula J, Nazarian SH, Lucas A, McFadden G.

Annu Rev Immunol. 2003;21:377-423. Epub 2001 Dec 19. Review.

PMID:
12543935
5.

Innate and acquired immunity intersect in a global view of the acute-phase response.

Yoo JY, Desiderio S.

Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1157-62. Epub 2003 Jan 22.

6.

Viral mimicry of cytokines, chemokines and their receptors.

Alcami A.

Nat Rev Immunol. 2003 Jan;3(1):36-50. Review.

PMID:
12511874
7.

Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor.

Stamos J, Sliwkowski MX, Eigenbrot C.

J Biol Chem. 2002 Nov 29;277(48):46265-72. Epub 2002 Aug 23.

8.

Small molecule inhibitors of the class 1 receptor tyrosine kinase family.

Cockerill GS, Lackey KE.

Curr Top Med Chem. 2002 Sep;2(9):1001-10. Review.

PMID:
12171567
9.

Potential benefits of the irreversible pan-erbB inhibitor, CI-1033, in the treatment of breast cancer.

Allen LF, Lenehan PF, Eiseman IA, Elliott WL, Fry DW.

Semin Oncol. 2002 Jun;29(3 Suppl 11):11-21. Review.

PMID:
12138393
10.

Epidermal growth factor receptor tyrosine kinase inhibitors.

Wakeling AE.

Curr Opin Pharmacol. 2002 Aug;2(4):382-7. Review.

PMID:
12127870
11.

Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy.

Citri A, Alroy I, Lavi S, Rubin C, Xu W, Grammatikakis N, Patterson C, Neckers L, Fry DW, Yarden Y.

EMBO J. 2002 May 15;21(10):2407-17.

12.

Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors.

Soubeyran P, Kowanetz K, Szymkiewicz I, Langdon WY, Dikic I.

Nature. 2002 Mar 14;416(6877):183-7. Erratum in: Nature 2002 May 2;417(6884):102.

PMID:
11894095
13.

Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung.

Chen HD, Fraire AE, Joris I, Brehm MA, Welsh RM, Selin LK.

Nat Immunol. 2001 Nov;2(11):1067-76.

PMID:
11668342
14.

Untangling the ErbB signalling network.

Yarden Y, Sliwkowski MX.

Nat Rev Mol Cell Biol. 2001 Feb;2(2):127-37. Review.

PMID:
11252954
15.

Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90.

Xu W, Mimnaugh E, Rosser MF, Nicchitta C, Marcu M, Yarden Y, Neckers L.

J Biol Chem. 2001 Feb 2;276(5):3702-8. Epub 2000 Nov 8.

16.

Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

Henderson DA, Inglesby TV, Bartlett JG, Ascher MS, Eitzen E, Jahrling PB, Hauer J, Layton M, McDade J, Osterholm MT, O'Toole T, Parker G, Perl T, Russell PK, Tonat K.

JAMA. 1999 Jun 9;281(22):2127-37. Review.

PMID:
10367824
17.

Antiviral drugs.

Balfour HH Jr.

N Engl J Med. 1999 Apr 22;340(16):1255-68. Review. No abstract available.

PMID:
10210711
18.
19.

Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network.

Tzahar E, Moyer JD, Waterman H, Barbacci EG, Bao J, Levkowitz G, Shelly M, Strano S, Pinkas-Kramarski R, Pierce JH, Andrews GC, Yarden Y.

EMBO J. 1998 Oct 15;17(20):5948-63.

20.

Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor.

Fry DW, Bridges AJ, Denny WA, Doherty A, Greis KD, Hicks JL, Hook KE, Keller PR, Leopold WR, Loo JA, McNamara DJ, Nelson JM, Sherwood V, Smaill JB, Trumpp-Kallmeyer S, Dobrusin EM.

Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):12022-7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk